Arena gets $800 million upfront in blockbuster lung drug deal

Arena gets $800 million upfront in blockbuster lung drug deal
/

Arena Pharmaceuticals will get $800 million cash upfront in a mammoth global drug commercialization deal announced Thursday.

The San Diego biomedical company licensed its lung disease drug, ralinepag, to North Carolina?s United Therapeutics Corp. In addition to the upfront payment, Arena is eligible…